Search results
HFT Scan: Ceat and India Cements in focus
CNBC Awaaz· 3 hours agoCeat and India Cements closed higher on June 28.
Nifty rides with bulls, can hit 24,600: Analysts
The Economic Times· 4 hours agoNifty could extend its gains as momentum remains strong with technical charts suggesting a positive bias. Analysts recommend stocks such as Reliance,...
Bain Capital-backed Emcure Pharma IPO to open on July 3: Namita Thapar to offload stake—Top 10...
Livemint· 14 hours agoEmcure Pharma IPO: The Bain Capital-backed IPO is a combination of fresh issue and offer for sale...
Nifty 50 July series: From Vedanta to Biocon—4 stocks where investors can park their money; Do you...
Livemint· 15 hours agoDomestic equity benchmarks Sensex and Nifty 50 ended June with their best gain in 2024, boosted by...
Dalal Street Week Ahead: FOMC minutes, Auto sales, FII activity among 10 key factors to watch next...
CNBC Awaaz· 23 hours agoThe market is expected to trade sideways next week due to the absence of strong buying or selling...
India's T20 Triumph: From Anand Mahindra To Sundar Pichai; The Business Paradigm Joins The ICC World...
Free Press Journal· 24 hours agoThe world's fifth-largest economy's business horizon also joined these jubilant celebrations online. Mahindra group head Anand Mahindra, who is known for his active participation online, took ...
Dividend Stocks: M&M, Piramal Ent, Tata Power, among others to trade ex-dividend next week; Check...
Livemint· 2 days agoDividend Stocks: Several companies including Mahindra & Mahindra, Piramal Enterprises, Tata Power,...
Biocon Biologics Receives EMA Approval to Manufacture Bevacizumab in India
SiliconIndia· 2 days agoTeam siliconindiaBiocon Biologics, a subsidiary of Biocon, received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab in India. This ...
India to manufacture medication for diabetes, obesity under PLI by 2026: Report
Firstpost· 3 days agoIncentives are being planned by India in 2026 to encourage domestic production of GLP-1 medications,...
Defence component supplier TechEra Engineering to raise Rs 35 crore via IPO
CNBC Awaaz· 3 days agoThe price band is estimated to be in the range of Rs 75-80 and the company is looking to list by the second half of July, according to a person familiar with the process.